Newsletter Archive
-
02.21.24 -- Addimmune's Quest For A Functional HIV Cure
2/21/2024
02/21/24 Life Science Leader Newsletter
-
02.21.24 -- Nanoparticle Enabled Formulation And Drug Delivery Solutions
2/21/2024
02/21/24 Life Science Leader Newsletter
-
02.19.24 -- Dynavax's Reorg And Return To Growth
2/19/2024
02/19/24 Life Science Leader Newsletter
-
02.16.24 -- Using AI For Rare Disease Drug Development
2/16/2024
02/16/24 Life Science Leader Newsletter
-
02.14.24 -- Mitigating ESG Risks Due To Antimicrobial Resistance
2/14/2024
02/14/24 Life Science Leader Newsletter
-
02.12.24 -- Gene Editing Versus Gene Therapy
2/12/2024
02/12/24 Life Science Leader Newsletter
-
02.09.24 -- Insights From Animals And Evolution
2/9/2024
02/09/24 Life Science Leader Newsletter
-
02.09.24 -- Listen Now: Allogeneic Drivers In 2024, Building A Biotech Hub, Multimodal R&D and more!
2/9/2024
02/09/24 Life Science Leader Newsletter
-
02.08.24 -- Gene Therapy Advancements: Natural History Studies And Rare Disease Milestones
2/8/2024
02/08/24 Life Science Leader Newsletter
-
02.07.24 -- Are Two Brands Better Than One?
2/7/2024
02/07/24 Life Science Leader Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more